SAN DIEGO, Jan. 09, 2018 -- Counterpoint Mutual Funds, LLC, announced today Morningstar, Inc., a provider of data and research insights on a wide range of investment offerings, has assigned Counterpoint Tactical Income Fund a Five Star rating out of 275 funds in the Nontraditional Bond category for the 3 year period ending 12/31/2017 based on risk adjusted returns.
|
|||
During the past three years, Counterpoint Tactical Income’s returns have ranked in the top 3rd percentile among 275 nontraditional bond funds with three years of performance history, according to Morningstar. By Morningstar’s definition, “The Nontraditional Bond category contains funds that pursue strategies divergent in one or more ways from conventional practice in the broader bond-fund universe.”
"We are excited to make our Morningstar star rating debut with the highest possible rating," said Michael Krause, CFA, co-founder of Counterpoint Mutual Funds and portfolio manager of Tactical Income. "This gives us the validation we’ve worked for during the initial phases of the fund’s life. We look forward to continuing to pursue Tactical Income’s long term goal of effectively managing risk while seeking reasonable returns for our clients."
Using a quantitative trend-following model, Counterpoint Tactical Income Fund seeks absolute returns via exposure to high yield bond assets during favorable market environments, and seeks a “risk-off” position in short-duration U.S. Treasuries during times of market stress.
“We believe that tactical allocation to high yield bond assets provides a particularly attractive opportunity to investors. Its exposure to offsetting risk factors, interest rate risk and credit risk, position it as an ideal asset class for our trend-following discipline,” said Michael Krause, CFA, co-founder of Counterpoint Mutual Funds and portfolio manager of Tactical Income.
“We continue to maintain our focus on managing downside risk and portfolio drawdowns. We believe this focus reduces investor anxiety and helps prevent our clients from making the wrong decisions during times of market stress,” said Krause.
Counterpoint Tactical Income Fund Institutional shares trade under the ticker CPITX, A shares trade under the ticker CPATX, and C Shares trade under ticker symbol CPCTX.
ABOUT COUNTERPOINT: Counterpoint Mutual Funds, LLC, is an adviser to alternative open-ended mutual funds. Our focus is on quantitative investment strategies that base asset allocation and security selection decisions on academic research and statistical analysis. Our funds seek innovative management strategies, tactical approaches to risk management, and reduction in volatility of returns. Our team consists of experienced investment management professionals and academic researchers who identify and evaluate novel investment strategies.
Contact
Counterpoint Mutual Funds, LLC
12760 High Bluff Drive, Suite 280
San Diego, CA 92130
Phone: 818-427-1999
Email: [email protected]
Website: http://www.counterpointmutualfunds.com/tactical-income-fund/performance-and-holdings/
Disclosures
Morningstar is an independent provider of financial information. Morningstar performance rankings are based on total return without sales charge relative to all share classes of mutual funds with similar objectives and determined by Morningstar. The top 10% of the funds in a rating universe receive five stars, the next 22.5% receive four stars, the next 35% receive three stars, the next 22.5% receive two stars and the bottom 10% receive one star. Past performance or ranking is not indicative of future results.
There is no assurance the Fund will meet its stated objective. Investors should carefully consider the investment objectives, risks, charges and expenses of the Counterpoint Tactical Income Fund. This and other important information about the Fund is contained in the prospectus, which can be obtained at counterpointmutualfunds.com or by calling 844-273-8637. The prospectus should be read carefully before investing. The Counterpoint Tactical Income Fund is distributed by Northern Lights Distributors, LLC member FINRA/SIPC.
4025-NLD-1/5/2018


Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Instagram Outage Disrupts Thousands of U.S. Users
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 



